The Incidence and Treatment Response of Double Expression of MYC and BCL2 in Patients with Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Diffuse large B-cell lymphoma (DLBCL) with co-expression of MYC and BCL2 proteins is referred to as double expressor lymphoma. Multiple studies have identified double expressor status to be an adverse predictive factor for response to standard chemotherapy regimens. The revised 2016...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Jisun, Suh, Chonghyun, Kim, Kyungwon, Kim, Hosung, Kim, Austin I., Craig, Jeffrey W., Chen, Ke Xun, Roberson, Joel, Guenette, Jeffrey P., Huang, Raymond Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268769/
https://www.ncbi.nlm.nih.gov/pubmed/34282799
http://dx.doi.org/10.3390/cancers13133369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268769/
https://www.ncbi.nlm.nih.gov/pubmed/34282799
http://dx.doi.org/10.3390/cancers13133369

Ejemplares similares